L&A Morales Healthcare/ Enrique Villa, MD Principal Investigator Trials

L&A Morales Healthcare/ Enrique Villa, MD Principal Investigator	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Kaseb, Ahmed

NCT02940496: Pembrolizumab With or Without Elbasvir/Grazoprevir and Ribavirin in Treating Patients With Advanced Refractory Liver Cancer

Completed

Elbasvir/Grazoprevir, Zepatier (BR); Elbasvir-Grazoprevir (SY); Grazoprevir/Elbasvir (SY); Grazoprevir-Elbasvir (SY); MK-8742/ MK-5172 (CN), Laboratory Biomarker Analysis, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475, Ribavirin, 1-.beta.-D-Ribofuranosyl-1H-1,2, 4-triazole-3-carboxamide, Copegus, ICN 1229, ICN-1229, Rebetol, RIBA, RTCA, Viramide, Virazid, Virazole

M.D. Anderson Cancer Center, National Cancer Institute (NCI)

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Hepatitis C Infection, Refractory Liver Carcinoma, Stage III Hepatocellular Carcinoma AJCC v7, Stage IIIA Hepatocellular Carcinoma AJCC v7, Stage IIIB Hepatocellular Carcinoma AJCC v7, Stage IIIC Hepatocellular Carcinoma AJCC v7, Stage IV Hepatocellular Carcinoma AJCC v7, Stage IVA Hepatocellular Carcinoma AJCC v7, Stage IVB Hepatocellular Carcinoma AJCC v7

08/23

BOSS-002, NCT05785390: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Terminated

170

NP-101, TQ Formula, Placebo

Novatek Pharmaceuticals

COVID-19

05/25

NCT04721132: Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer

Active, not recruiting

Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG7446, RO5541267, Tecentriq, Bevacizumab, Anti-VEGF, Anti-VEGF Humanized Monoclonal Antibody, Anti-VEGF rhuMAb, Avastin, Bevacizumab awwb, Bevacizumab Biosimilar BEVZ92, Bevacizumab Biosimilar BI 695502, Bevacizumab Biosimilar CBT 124, Bevacizumab Biosimilar CT-P16, Bevacizumab Biosimilar FKB238, Bevacizumab Biosimilar GB-222, Bevacizumab Biosimilar HD204, Bevacizumab Biosimilar HLX04, Bevacizumab Biosimilar IBI305, Bevacizumab Biosimilar LY01008, Bevacizumab Biosimilar MIL60, Bevacizumab Biosimilar Mvasi, Bevacizumab Biosimilar QL 1101, Bevacizumab Biosimilar RPH-001, Bevacizumab Biosimilar SCT501, Bevacizumab Biosimilar Zirabev, Bevacizumab-awwb, Bevacizumab-bvzr, BP102, BP102 Biosimilar, HD204, Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer, Mvasi, Recombinant Humanized Anti-VEGF Monoclonal Antibody, rhuMab-VEGF, SCT501, Zirabev, Therapeutic Conventional Surgery

M.D. Anderson Cancer Center

Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8, Stage IB Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8

05/27

12/27

NCT03897543: ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

Recruiting

1/2

ABX196

Abivax S.A., C3 Research Associates

Carcinoma, Hepatocellular

06/21

06/23

Gutierrez, Anya

NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)

Completed

1453

Placebo, Montelukast

Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center

Covid19

07/23

01/24

NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications

Completed

10956

Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin

Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center

Covid19

04/24

NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)

Completed

3214

Placebo, Metformin

Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center

Covid19

06/24

11/24

NCT04247542: ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Completed

Ibezapolstat, ACX-362E, Vancomycin, Vancomycin oral

Acurx Pharmaceuticals Inc.

Clostridium Difficile Infection

10/23

11/23

BOSS-002, NCT05785390: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Terminated

170

NP-101, TQ Formula, Placebo

Novatek Pharmaceuticals

COVID-19

05/25

NCT05732610: MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

Completed

N/A

MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)

Medical Group Care, LLC, CSSi Life Sciences

COVID-19, Influenza A, Influenza B

02/23

03/23

NCT05771714: Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test

Terminated

N/A

786

CareSuperb COVID-19 Antigen Home Test Kit

AccessBio, Inc.

COVID-19

05/23

ARGONAUT, NCT04638751: Stool and Blood Sample Bank for Cancer Patients

Recruiting

N/A

5000

Immunotherapy, Chemotherapy, CRC surgical resection, Colonoscopy

Persephone Biosciences

Non-small Cell Lung Cancer, Colorectal Cancer, Triple Negative Breast Cancer, Pancreas Cancer

12/24

12/25

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Kaseb, Ahmed

NCT02940496: Pembrolizumab With or Without Elbasvir/Grazoprevir and Ribavirin in Treating Patients With Advanced Refractory Liver Cancer

Completed

M.D. Anderson Cancer Center, National Cancer Institute (NCI)

08/23

BOSS-002, NCT05785390: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Terminated

170

NP-101, TQ Formula, Placebo

Novatek Pharmaceuticals

COVID-19

05/25

NCT04721132: Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer

Active, not recruiting

M.D. Anderson Cancer Center

05/27

12/27

NCT03897543: ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

Recruiting

1/2

ABX196

Abivax S.A., C3 Research Associates

Carcinoma, Hepatocellular

06/21

06/23

Gutierrez, Anya

NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)

Completed

1453

Placebo, Montelukast

Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center

Covid19

07/23

01/24

NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications

Completed

10956

Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin

Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center

Covid19

04/24

NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)

Completed

3214

Placebo, Metformin

Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center

Covid19

06/24

11/24

NCT04247542: ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Completed

Ibezapolstat, ACX-362E, Vancomycin, Vancomycin oral

Acurx Pharmaceuticals Inc.

Clostridium Difficile Infection

10/23

11/23

BOSS-002, NCT05785390: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Terminated

170

NP-101, TQ Formula, Placebo

Novatek Pharmaceuticals

COVID-19

05/25

NCT05732610: MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

Completed

N/A

MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)

Medical Group Care, LLC, CSSi Life Sciences

COVID-19, Influenza A, Influenza B

02/23

03/23

NCT05771714: Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test

Terminated

N/A

786

CareSuperb COVID-19 Antigen Home Test Kit

AccessBio, Inc.

COVID-19

05/23

ARGONAUT, NCT04638751: Stool and Blood Sample Bank for Cancer Patients

Recruiting

N/A

5000

Immunotherapy, Chemotherapy, CRC surgical resection, Colonoscopy

Persephone Biosciences

Non-small Cell Lung Cancer, Colorectal Cancer, Triple Negative Breast Cancer, Pancreas Cancer

12/24

12/25



	Diseases Companies Products Productz Mechanisms of Action Sites